HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of sucralfate and sulglycotide treatment on active gastritis and Helicobacter pylori colonization of the gastric mucosa in non-ulcer dyspepsia patients.

Abstract
We conducted a double-blind randomized treatment study on patients affects by non-ulcer dyspepsia in whom multiple biopsy specimens showed active gastritis. Patients were given either 3 g/day of sucralfate (n = 39) or 600 mg/day of sulglycotide (n = 50) for 6 wk, a glycopeptide isolated from pig duodenum constituents. Endoscopy was carried out at baseline and at the end of treatment. We took biopsies from the gastric body (twice) and antrum (six times) at each endoscopy in order to determine grade and extent of gastritis and Helicobacter pylori colonization. Both treatments induced a marked regression of active gastritis (sucralfate group: p less than 0.05 and p less than 0.0001, respectively, in body and in antrum; sulglycotide group: p less than 0.01 and p less than 0.001, respectively). Conversely, Helicobacter pylori colonization remained unchanged at the end of the treatments. At baseline, a close relationship was found between grade of active inflammation in each biopsy and Helicobacter pylori density. After therapy, the association was lost in each treatment group. These results suggest that there can be a remission of active gastritis in patients with non-ulcer dyspepsia even without changes in Helicobacter pylori colonization. This result can be achieved by enhancing the protective properties of the gastric mucosa.
AuthorsL Barbara, G Biasco, L Capurso, G Dobrilla, A Lalli, G M Paganelli, F Pallone, A Torsoli
JournalThe American journal of gastroenterology (Am J Gastroenterol) Vol. 85 Issue 9 Pg. 1109-13 (Sep 1990) ISSN: 0002-9270 [Print] United States
PMID2202200 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Ulcer Agents
  • Sialoglycoproteins
  • sulglicotide
  • Sucralfate
Topics
  • Adult
  • Aged
  • Anti-Ulcer Agents (therapeutic use)
  • Biopsy
  • Colony Count, Microbial
  • Corynebacterium (growth & development)
  • Corynebacterium Infections (drug therapy, pathology)
  • Double-Blind Method
  • Dyspepsia (drug therapy, pathology)
  • Female
  • Gastric Mucosa (microbiology)
  • Gastritis (drug therapy, pathology)
  • Humans
  • Male
  • Middle Aged
  • Randomized Controlled Trials as Topic
  • Retrospective Studies
  • Sialoglycoproteins (therapeutic use)
  • Sucralfate (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: